Corneal endothelial cell protection with Viscoat and Healon or Healon alone during penetrating keratoplasty
| Autor: | Kentaro Shimizu, Ryouhei Nejima, Takashi Miyai, Satoru Yamagami, Kazunori Miyata, Shiro Amano |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Adult
Graft Rejection Male Intraocular pressure medicine.medical_specialty Time Factors Corneal leukoma Sodium hyaluronate Cell Count Corneal Diseases chemistry.chemical_compound Adjuvants Immunologic Ophthalmology Medicine Humans Postoperative Period Hyaluronic Acid Intraocular Pressure Aged Retrospective Studies Aged 80 and over business.industry Significant difference Chondroitin Sulfates Endothelium Corneal Middle Aged eye diseases Single surgeon Surgery Drug Combinations Treatment Outcome chemistry Bullous keratopathy Corneal endothelial cell Drug Therapy Combination Female business Chondroitin Follow-Up Studies |
| Zdroj: | Cornea. 24(8) |
| ISSN: | 0277-3740 |
| Popis: | PURPOSE To determine the influence of dispersive ophthalmic viscosurgical products (OVPs) on corneal endothelial cell (CEC) density during penetrating keratoplasty (PKP) and on the postoperative intraocular pressure (IOP). METHODS In 117 eyes of 113 patients, PKP was performed by a single surgeon from April 1, 1998 to April 30, 2002. Loss of CECs and postoperative IOP were evaluated retrospectively after use of Viscoat (sodium hyaluronate 3.0%, chondroitin sulfate 4.0%) plus Healon (sodium hyaluronate 1.0%) (Viscoat/Healon group) or Healon alone (Healon group) during surgery. RESULTS The average CEC loss was 14.6 +/- 15.5% and 9.0 +/- 10.5% at 1 month, 18.1 +/- 14.6% and 10.1 +/- 7.3% at 3 months, 20.1 +/- 16.3% and 12.2 +/- 10.9% at 6 months, and 31.7 +/- 21.4% and 18.1 +/- 15.5% at 12 months in the Healon (n = 74) and Viscoat/Healon (n = 43) groups, respectively. Patients were stratified into groups with corneal leukoma (n = 61) or bullous keratopathy (n = 56). Loss of CECs was significantly smaller in the Viscoat/Healon group compared with the Healon group irrespective of whether patients had corneal leukoma or bullous keratopathy at 3, 6, and 12 months postoperatively. There was no significant difference of postoperative IOP between the Healon and Viscoat/Healon groups over 12 months of follow-up. CONCLUSION These results suggest that the addition of Viscoat to Healon decreases CEC loss during PKP and does not affect postoperative IOP. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|